Cambridge Investment Research Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
|
|||||
|
2025
Q1 | $140K | Buy |
|
|||||
|
2024
Q4 | $152K | Buy |
|
|||||
|
2024
Q3 | $214K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $227K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $257K | Buy |
|
|||||
|
2022
Q2 | $231K | Sell |
|
|||||
|
2022
Q1 | $356K | Sell |
|
|||||
|
2021
Q4 | $681K | Sell |
|
|||||
|
2021
Q3 | $1.48M | Buy |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|